Studies on heterocyclic compounds. II. Syntheses and pharmacologic activities of 1,3,5 triazine derivatives (Japanese)

DOI: 10.1248/yakushi1947.95.5_512

Source and publish data:

Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan p. 512 - 520 (1975)

Update date:2022-08-04

Topics:

Authors:

Tsujikawa

Tsukamura

Takei Takei

Sirakawa

Chiba Chiba

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/yakushi1947.95.5_512

Full text of DOI:10.1248/yakushi1947.95.5_512

NII-Electronic Library Service

Products guided by the article

Product name:4-methoxy-6-[2-(4-phenyl-piperazin-1-yl)-ethyl]-[1,3,5]triazin-2-ylamine

Cas No:5631-11-8

R&D Labs maybe for 5631-11-8

Jiaxing Anrui Material Technology Co., Ltd.

Contact:86-573-82651652 13305832579

Address:Room 407, Technology Building, 1369 Chennan Road, Jiaxing City, Zhejiang, China
GLD peptide scientific lnc.

Contact:21-7631221 15884421033

Address:326 Science and technology,Shanghai,China
ZiBO KuoDing Trade company Ltd

website:http://www.sdzbkd.com

Contact:86-13361591822

Address:GongQingTuan road
HANGZHOU YUNUO CHEMICAL CO.,LTD

website:http://www.yunuochem.com

Contact:0571-83715115

Address:hangzhou
Weifang Adde Economic And Trade Co.,LTD.

Contact:86-536-8885548

Address:Room 1402,Wanda Plaza B Block,No.958,Yuanfei Road,Kuiwen District

Relevant to this article

Doi:10.1039/jr9530000951
(1953)
Discovery of 5-substituted-N-arylpyridazinones as inhibitors of p38 MAP kinase

Doi:10.1016/j.bmcl.2010.03.088
(2010)
Preparation and properties of sterically protected diphosphene and fluorenylidenephosphine bearing the 2,6-di-tert-butyl-4-methoxyphenyl group

Doi:10.1246/cl.2003.430
(2003)
Alkyl substituent effects on reductive elimination reactions in zirconocene alkyl hydride complexes. Manipulation of the alkyl steric environment allows the synthesis of a zirconocene dinitrogen complex

Doi:10.1021/om0302239
(2003)
Doi:10.1021/ja00847a026
(1975)
Novel and potent human and rat β₃-adrenergic receptor agonists containing substituted 3-indolylalkylamines

Doi:10.1016/S0960-894X(03)00073-8
(2003)

Article Doi